Livio di Lecce

Livio Di Lecce has extensive experience in the pharmaceutical industry, with a strong background in medical affairs and leadership roles.

Livio is currently serving as the Medical Director at Intercept Pharmaceuticals since October 2021. Prior to that, Livio worked at UCB from 2018 to 2021, where they held the positions of Director, EU Medical Operations Lead from November 2019 to September 2021, and Medical Head from April 2018 to October 2019.

Before joining UCB, Livio worked at Daiichi Sankyo Europe GmbH as the Director of Medical Affairs from October 2015 to March 2018. Livio also has experience with Daiichi Sankyo, where they held various roles including Medical Manager from January 2015 to September 2015, Medical Advisor from October 2013 to December 2014, and Medical Science Liaison from April 2012 to September 2013.

Livio started their career at Sooft Italia in 2011, where they worked as a Scientific Advisor from April 2011 to March 2012. Prior to that, they were a Clinical Site Manager at Bristol-Myers Squibb from September 2009 to March 2011.

Overall, Livio Di Lecce's work experience demonstrates their expertise in medical affairs, leadership, and clinical research within the pharmaceutical industry.

Livio Di Lecce's education history includes attending the Università degli studi Roma TRE and the Università degli Studi di Bari. However, specific details about the start year, end year, degree name, and field of study are not provided.